Jennifer Lee

Jennifer Lee is a seasoned professional in clinical operations with extensive experience in overseeing clinical trials from initiation to completion. Currently serving as Sr. Director of Clinical Operations at Neogene Therapeutics, Jennifer has held various leadership positions at Kite Pharma, Caladrius Biosciences, Avanir Pharmaceuticals, Allergan, and Baxter Healthcare. Key responsibilities have included developing study strategies, managing cross-functional teams, vendor selection, and ensuring compliance with regulatory standards. Jennifer has a proven track record of meeting and exceeding enrollment and operational milestones across multiple therapeutic areas, with a strong background in diabetes, myocardial infarction, and other indications. Jennifer holds a B.S. in Exercise Biology from the University of California, Davis.